Nykredit A S Acquires Shares of 78,252 Cencora, Inc. $COR

Nykredit A S bought a new stake in Cencora, Inc. (NYSE:COR) in the 2nd quarter, Holdings Channel.com reports. The fund bought 78,252 shares of the company’s stock, valued at approximately $22,144,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Kemnay Advisory Services Inc. bought a new position in Cencora in the fourth quarter valued at about $25,000. Elyxium Wealth LLC bought a new stake in Cencora during the 4th quarter worth about $27,000. Motiv8 Investments LLC bought a new stake in Cencora during the 4th quarter worth about $29,000. Basepoint Wealth LLC acquired a new position in Cencora during the 4th quarter valued at about $32,000. Finally, Elevation Wealth Partners LLC lifted its position in Cencora by 506.2% during the 2nd quarter. Elevation Wealth Partners LLC now owns 97 shares of the company’s stock valued at $27,000 after purchasing an additional 81 shares during the period. Institutional investors own 97.52% of the company’s stock.

Insider Transactions at Cencora

In other news, Director Lauren M. Tyler bought 550 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The shares were acquired at an average price of $270.23 per share, with a total value of $148,626.50. Following the transaction, the director owned 4,359 shares in the company, valued at $1,177,932.57. This represents a 14.44% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Elizabeth Campbell sold 11,300 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $324.12, for a total value of $3,662,556.00. Following the completion of the sale, the executive vice president owned 19,455 shares in the company, valued at $6,305,754.60. The trade was a 36.74% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.38% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Evercore reiterated an “outperform” rating and set a $350.00 price target on shares of Cencora in a research report on Thursday, August 6th. Royal Bank Of Canada began coverage on shares of Cencora in a report on Wednesday, August 19th. They issued a “sector perform” rating and a $330.00 price objective on the stock. UBS Group raised their price objective on shares of Cencora from $412.00 to $430.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Wells Fargo & Company upped their target price on shares of Cencora from $331.00 to $395.00 and gave the company an “overweight” rating in a research report on Tuesday, August 11th. Finally, Wall Street Zen raised Cencora from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $370.85.

Cencora Stock Up 0.1%

Shares of NYSE COR opened at $336.77 on Friday. The stock has a market cap of $64.27 billion, a P/E ratio of 25.02, a P/E/G ratio of 1.91 and a beta of 0.57. The firm has a 50 day moving average price of $311.45 and a 200 day moving average price of $309.74. The company has a debt-to-equity ratio of 3.53, a quick ratio of 0.58 and a current ratio of 0.93. Cencora, Inc. has a 52-week low of $244.82 and a 52-week high of $377.54.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, August 5th. The company reported $4.48 earnings per share for the quarter, topping the consensus estimate of $4.35 by $0.13. The company had revenue of $84.75 billion for the quarter, compared to analyst estimates of $84.31 billion. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The business’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period last year, the business posted $4.00 earnings per share. Analysts expect that Cencora, Inc. will post 17.87 EPS for the current year.

Cencora declared that its Board of Directors has approved a stock buyback program on Thursday, May 21st that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to reacquire up to 3.9% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s management believes its stock is undervalued.

Cencora Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Friday, August 14th. Cencora’s dividend payout ratio is currently 17.83%.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.